To date, available clinical experience primarily derived from populations with T2DM or obesity receiving concomitant immunomodulatory therapies has not revealed major safety signals related to increased infection risk or immune suppression
Weight changes typically begin in week 2-3, with the most noticeable effects occurring between weeks 4-16
It works primarily by suppressing appetite, slowing gastric emptying, and increasing energy expenditure
Lyzenga-Dean explains, "Flavonoids are a family of compounds that have been shown to be particularly effective at increasing GLP-1 hormone production from the gut." Common sources include curcumin from turmeric, cinnamon, rosemary, and EGCG from green tea
Appetite, cravings, and food noise
For related coverage, see What Is Retatrutide